Vaccine delivery systems using yeast cell wall particles
The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.
1. A composition for delivering a vaccine, comprising (i) a yeast cell wall particle; (ii) a silicate; and (iii) an exogenous biological material loaded within the particle, wherein the yeast cell wall particle is modified by coating with the silicate, and wherein the biological material comprises tumor lysate.
2. A method for treating an infectious disease, comprising administering to a subject a composition comprising (i) a yeast cell wall particle; (ii) a silicate, and (iii) an exogenous biological material loaded within the particle, wherein the biological material comprises a tumor lysate, and wherein the yeast cell wall particle is coated with the silicate.
3. A method for treating cancer, comprising administering to a subject a composition comprising (i) a yeast cell wall particle; (ii) a silicate, and (iii) an exogenous biological material loaded within the particle, wherein the biological material comprises a tumor lysate, and wherein the yeast cell wall particle is coated with the silicate.
4. A method for preparing a composition comprising a yeast cell wall particle and a silicate, comprising contacting the yeast cell wall particle with the silicate in the presence of ammonia such that the yeast cell wall particle is capped by the silicate.
5. The method of claim 4 , wherein the silicate comprises an organic moiety attached to each of the four oxygen compounds of an orthosilicate.
6. The method of claim 4 , wherein the silicate is tetraethylorthosilicate, tetramethylorthosilicate, tetrapropylorthosilicate, or tetrabutylorthosilicate.
7. A method for producing a cell mixture containing a yeast cell wall particle loaded with a biological material and capped with a silicate, comprising:
(i) loading a biological material into a yeast cell wall particle to produce a loaded particle;
(ii) capping the loaded particle with a silicate;
(iii) freeze-drying the capped, loaded particle; and
(iv) incubating the capped, loaded particle with a cell of monocytic origin
wherein the incubation causes the cell of monocytic origin to phagocytose the capped, loaded particle.
8. The method of claim 7 , wherein the cell of monocytic origin is a pre-dendritic cell, a dendritic cell, or a partially differentiated dendritic cell.
9. The method of claim 7 , wherein the biological material is selected from the group consisting of a specific protein or a fragment thereof, nucleic acid, carbohydrate, tumor lysate, and a combination thereof.
10. The method of claim 7 , wherein step (i) comprises:
(a) suspending a yeast cell wall particle and a biological material in a diluent and incubating for a period of time to allow the biological material to be absorbed by the yeast cell wall particle; and
(b) freeze-drying the suspension to load the biological material within the yeast cell wall particle.
11. The method of claim 10 , wherein steps (a) and (b) are repeated at least once.
12. The method of claim 7 , wherein the biological material is selected from the group consisting of a specific protein or a fragment thereof, nucleic acid, carbohydrate, tumor lysate, and a combination thereof.
13. The method of claim 7 , wherein the silicate is tetraethylorthosilicate, tetramethylorthosilicate, tetrapropylorthosilicate, or tetrabutylorthosilicate.